The first update to An Action Agenda to End AIDS gives a status report on key actions and provides priority recommendations.
An Action Agenda to End AIDS: Quarterly monitoring report
A New Way to Protect Against HIV? Understanding the Results of Male Circumcision Studies
A 2007 document discussing the results of three large efficacy trials of voluntary medical male circumcision (VMMC) as an HIV prevention strategy. It proposes key priorities for additional research and preparing for implementation.
An Action Agenda to End AIDS: Quarterly monitoring report
The second update to An Action Agenda to End AIDS gives a status report on key actions and provides priority recommendations.
Voluntary Medical Male Circumcision (VMMC) Device Evaluations Map and Table
One-page resource on non-surgical device evaluation in Africa as of late 2013.
Frequently Asked Questions on Non-Surgical Devices for Voluntary Medical Male Circumcision for HIV Prevention
Basic information on non-surgical devices with a focus on the implications of WHO prequalification and next steps for product introduction.
An Action Agenda to End AIDS: Where are we in realizing the promise of beginning to end AIDS?
Issued in 2013, a year after An Action Agenda to End AIDS was first published, this document gives a status report on key actions and provides priority recommendations.
A Cascade of Hope and Questions: Anticipating results of ARV-based HIV prevention trials
A report designed to help advocates understand results of the 2010 CAPRISA 004 trial and how they related to the research agenda for ARV-based prevention strategies.
Understanding the Results of CAPRISA 004
A 2010 document discussing the results of the CAPRISA 004 microbicide gel trial. It explores the implications of the data and outlines the next steps in evaluating tenofovir gel.
From Research to Reality: Investing in HIV prevention research in a challenging landscape
Summary of findings from report on 2012 investment and funding trends in HIV prevention research and development (R&D).
Next steps for PrEP: Getting a proven prevention option to the people who need it
An article from the June 2013 edition of the GMHC newsletter discussing issues of PrEP introduction worldwide, reviewing efficacy trial results and current status of regulatory approval of Truvada as PrEP and rollout efforts.